|

Depression Clinical Trials in Miami, FL

49 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderPhase 3<1 mi
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study—<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"Phase 3<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant DepressionN/A<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPhase 3<1 mi
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIVN/A<1 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPhase 4<1 mi
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIVN/A<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionPhase 2<1 mi
Neural and Psychiatric Consequences of Cannabis Use in AdolescentsN/A<1 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)Phase 3<1 mi
Clinical Trial on Agitation in Alzheimer's DementiaPhase 2<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Phase 2<1 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderPhase 3<1 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsPhase 3<1 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderPhase 3<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)Phase 2<1 mi
Mental Health in Primary CareN/A<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Phase 3<1 mi
Cocooned Moms StudyN/A<1 mi
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) InhibitorPhase 4<1 mi
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)N/A<1 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolPhase 3<1 mi
Implementing Depression and Adherence TreatmentN/A<1 mi
ENA-001 for Opioid Induced Respiratory DepressionPhase 1<1 mi
An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms—<1 mi
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderPhase 3<1 mi
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)Phase 2<1 mi
Families With Pride ("Familias Con Orgullo").N/A6 mi
Geolocation Positional System (GPS) ExperienceN/A6 mi
Unified Protocol: Community ConnectionsN/A6 mi
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With DepressionPhase 29 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.Phase 211 mi
Study of ALTO-300 in MDDPhase 213 mi
A Study of Brenipatide in Adult Participants With Major Depressive DisorderPhase 313 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 313 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant ResponsePhase 217 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age—17 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 317 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderPhase 217 mi
The Student Wellness and Emotional Growth Resiliency (SWAG-R) ProgramN/A25 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)Phase 226 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)Phase 226 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.